Medinotec (MDNC) EBT Growth (1y) (2023 - 2026)
Medinotec (MDNC) EBT Growth (1y) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 181.32 Bn | 174.03 Bn | 6.27 Bn | -18.50% |
| 2 | Stryker | 128.59 Bn | 125.71 Bn | 3.81 Bn | 11.26% |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 45.44% |
| 4 | Boston Scientific | 67.77 Bn | 66.32 Bn | 3.61 Bn | 44.35% |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.46 Bn | 1.29 Bn | 5.78% |
| 6 | GE HealthCare Technologies | 28.44 Bn | 26.15 Bn | 1.98 Bn | -27.02% |
| 7 | Dexcom | 28.41 Bn | 27.29 Bn | 750.30 Mn | 74.66% |
| 8 | Smith & Nephew | 26.77 Bn | 26.20 Bn | - | - |
| 9 | Koninklijke Philips | 25.24 Bn | 22.11 Bn | 2.07 Bn | 103.34% |
| 10 | Medinotec | 58.78 Mn | 58.19 Mn | 1.31 Mn | -20.65% |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2026 | -20.65% |
| Feb 28, 2026 | -73.34% |
| Nov 30, 2025 | -46.11% |
| Aug 31, 2025 | 10,331.03% |
| May 31, 2025 | 22.71% |
| Feb 28, 2025 | 1,529.85% |
| Nov 30, 2024 | 212.14% |
| Aug 31, 2024 | 83.47% |
| May 31, 2024 | 953.91% |
| Feb 29, 2024 | 430.54% |
| Nov 30, 2023 | -2,458.54% |
| Aug 31, 2023 | 85.53% |
| May 31, 2023 | 138.26% |
| Feb 28, 2023 | 118.65% |